4 0
DNase-1. Digested lung tissue was subsequently passed through a 40 µM cell strainer 1 4 1 and centrifuged at 300 g for 10 min at 4ºC. RBC lysis was carried out in the cell pellet All PRR agonists employed in the studies were verified endotoxin-free as indicated by the were euthanized 4 or 24 h after intranasal administration and lung and or lung draining 1 7 9 lymph nodes were harvested to determine the uptake, trafficking, phenotype and antigen 1 8 0 degradation (27). To enumerate the antigen cross presentation, DCs from the draining 1 8 1 lymph nodes were stained with anti-mouse Kb-SIINFEKL Abs, and data was acquired on 1 8 2 BD Fortessa flow cytometer. Sidak multiple comparison post-test. Results were considered significant at p < 0.05, and 1 9 0 indicated as follows: *p<0.05, **p<0.01, ***p<0.001, ****p<0.001. To prepare single cell suspensions, neonates and adult mice were sacrificed and lungs 1 9 6 isolated, digested and enriched for CD11c + cell fractions ( Fig. 1A) . A panel of reliable and 1 9 7 cell surface makers were used in combination to identify heterogeneous populations of 1 9 8 lung APCs studied in this article ( Fig. 1B-C) . As mucosal APCs are heterogeneous, we 1 9 9 employed a stringent gating strategy to distinguish the different subsets and their 2 0 0 progenitors. By using the combination of different surface markers and a hierarchal gating 2 0 1 strategy, we identified alveolar macrophages (AMs), moDCs, CD103 + DCs, CD11b + DCs 2 0 2 and pDCs ( Fig. 2A ). While the percentage of Ly6C + cells was significantly higher in 2 0 3 neonatal vs. adult mice (Fig. 2B) , and AMs and moDCs subsets were similar between 2 0 4 both age groups, neonates demonstrated a significanly lower percentage of lung DC 2 0 5 subsets CD103 + DCs (n = 12, P < 0.001), CD11b + DCs (P < 0.001) and pDCs (P < 0.05) 2 0 6 ( Fig. 2C ). Quite interestingly, while both adult and neonatal antigen uptake capability was 2 0 7 similar for all the major APC subsets ( Figure 3A ), CD103 + and CD11b + DCs from 2 0 8 neonates showed relatively lower expression of basal co-stimulatory molecules CD40 2 0 9 (CD11b + (n = 12, P < 0.001) and CD103 + (P < 0.01) DCs), CD80 (P < 0.001) and CD86 2 1 0 (P < 0.001) ( Fig. 3C-D) . These observations demonstrated that neonatal murine lung 2 1 1 APCs contain a greater proportion of phenotypically distinct immature DC precursor cells, including CD103 + and CD11b + DCs, relative to their adult counterparts. Our observations regarding the phenotype of DC subsets in neonatal murine lungs 2 1 7 indicated an intrinsic age-specific difference in the percentages and maturation status of subsets to stimuli such as PRR agonist adjuvants may also be distinct. To test this 2 2 0 hypothesis, we stimulated CD11c + cells isolated from the lungs of different aged mice and 2 2 1 stimulated them with different classes of PRR receptor agonists at a concentrations 2 2 2 reported most active for bone marrow DC activation (24, 25) . We then summarized the form < 1 to > 4.5) for CD40, CD80 and CD86, per F4/80, CD11b, CD103 PDCA-1 APC 2 2 6 subsets, as compared with un-stimulated controls per age group. Overall, unique 2 2 7 activation and maturation patterns were observed by stimuli, age, marker and APC subset 2 2 8 ( Fig. 4 ). Ranking by sum fold change activation, CpG ODN ranked first in adult mice. Flagellin ranked first in the ability to mature neonatal lung APCs (Fig. 4 ). While the 2 3 0 responses of mucosal APC subsets to PRR agonists TLR1 (PAM3CSK), TLR2 2 3 1 (PAM2CSK), and TLR3 (Poly I:C) were impaired in general, we noted that all the neonatal to these ligands, TLR5 agonist flagellin and STING agonist 2'3'-cGAMP specifically and all the DC subsets from the neonates and adult mice. These observations demonstrate 2 3 8 functional differences in the major APC subsets of murine lungs and highlight flagellin and 2 3 9 2'3'-cGAMP as a potential activators of mucosal immunity in early life. with the in vitro co-stimulatory molecule stimulation data, and when ranked by MFI, as compared to adults (P < 0.05), neonatal lung CD11c+ DCs CCR9 expression was not 2 5 5 significantly increased (Fig. 5C ). We also noted that the APCs from the neonates did not these observations suggest that flagellin adjuvant in neonates, but not necessarily adult show poor MHC-I presentation of OVA peptides (i.e., SIINFEKL), which was potentially Together, these studies show that TLR5 signaling plays an important role in the approaches and as compared to the established regimen applied to adults. only to provide the protection against infections but also to activate the adaptive arm of often-inefficient adaptive responses (31). In the present study, we numerically, 3 3 4 phenotypically and functionally characterized the APCs isolated from neonates and adult 3 3 5 mice lungs and monitored their response to different PRR stimuli. In the CD11c enriched 3 3 6 cells, we identified mature APCs as MHC-II high , and four major APC precursors were 3 3 7 gated based on the expression of Ly6C +/and CD11b +/in the MHC-II low population. CD11b + migDC subsets, while the percentages of Ly6C + precursor cells were abundant. Low percentages and qualitative differences in migDC subsets correlate with the RSV 3 4 1 infection severity in the neonatal mice lungs (31). However, the Ly6C + CD11b + monocytic 3 4 2 precursor population has not been fully explored for the transcriptional and functional 3 4 3 characteristics to identify the molecular pathways, which can be targeted to derive the 3 4 4 mature APC and cDC populations. Remarkably, we noted that neonatal mice showed a the antigen uptake capacities of all the APC subsets isolated from neonates and adults. observations, we speculate that the low abundance or immature phenotype of migDCs For functional characterization of these APC subsets, we stimulated CD11c 3 5 7 enriched cells with different PRR agonists and investigated the expression of maturation chemotaxis, but also migrate to the draining lymph nodes and initiate the adaptive arm of Similarly, among all the stimuli employed, TLR5 agonist flagellin activated neonatal 3 7 0 migDCs more robustly and upregulated the expression of lymph node homing receptor 3 7 1 CCR7 on neonatal migDCs. These findings corroborate many studies which highlight only acts as an antigen, but is also a very useful tool to study the antigen processing and Another intriguing finding of our study is the differences in the lysosomal 3 8 4 processing of antigens at an early age. DQ-OVA proteolytic cleavage emits the green the antigen uptake across both the subsets, neonatal CD103 + DCs showed very rapid which signifies poor antigen cross presentation in vivo. We also looked at the antigen 3 9 0 processing capacities of isolated lung migDC subsets, and observed a striking difference 3 9 1 in the DQ-OVA processing which signify the endosomal defects in the cross-presenting 3 9 2 machinery of CD103 + DCs. However, flagellin stimulation revived phagosomal maturation 3 9 3 and overcame the slow perivascular accumulation of antigens. We also studied OVA 3 9 4 peptide presentation on MHC-I using anti-SINFFKEL antibodies specific for ik-ab in vivo, 3 9 5 and our results show that flagellin co-administration significantly increased the antigen 3 9 6 presentation on MHC-I. These findings suggest that TLR5 signaling in CD103 + DC plays an important role in the priming of antigen cross-presentation. However, there is also of life) and is maintained throughout life thereafter. Our studies provide further support for 4 1 8 an ontologically driven cDC2:cDC1 ratio in the lung, and refine it to specially highlight a 4 1 9 cDC1 dominance in the neonatal period that is supplanted by cDC2 subsets in infancy. twenty-first century society. Nat Rev Immunol 11: 865-872. Immunol 198: 557-563.
